Zileuton Sulfoxide is an oxidation derivative of the parent drug Zileuton, featuring a sulfoxide (S=O) group in place of the thioether linkage present in the active pharmaceutical ingredient. Its structure incorporates a 1,3-thiadiazole ring fused to a substituted pyridine, with an ester functionality at the 5-position. The sulfoxide moiety introduces a chiral center, resulting in diastereomeric forms. This compound arises as a degradation byproduct under oxidative stress conditions. It serves as a critical HPLC reference standard for quantifying oxidative degradation pathways in Zileuton formulations.
On RequestCC(C1=CC2=CC=CC=C2S1=O)N(C(=O)N)O
InChI=1S/C11H12N2O3S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)17(10)16/h2-7,15H,1H3,(H2,12,14)
KWEAXQJUQDQMNY-UHFFFAOYSA-N